Does eradication of helicobacter pylori infection reduce hypergastrinema during long term therapy with proton pump inhibitors?

Turkish Journal of Gastroenterology

Volumn 13, Issue 3, 2002, Pages 159-163

  Gürbüz, Ahmet K ^a   Küçükkardali, Yaşar ^a   Yazgan, Yusuf ^a   Özel, Melih ^a   Polat, Taner ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Helicobacter pylori; Hypergastrinemia; Proton pump inhibitors

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; GASTRIN; LANSOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ERADICATION THERAPY; FEMALE; GASTRIN BLOOD LEVEL; HELICOBACTER INFECTION; HUMAN; HYPERGASTRINEMIA; MALE; STATISTICAL ANALYSIS;

EID: 0036747885     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Forman D. The prevalence of H. pylori infection in gastric cancer. Aliment Pharmacol Ther 1995; 9: 71-6.
2. Konturek JW, Gillisen A, Konturek SW. Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcers patients. Gut 1995; 37: 482-7.
3. Lewin DN, Nzortoku W. Infection with H.Pylori, Schistostomes, Liver Flukes and H. Pylori. IARC monographs on the evaluation of carcinogenic risks to humans, IARC, Lyon, France. 1944; 61: 177-240.
4. Moss SF, Legos S, Bishop AE, et al. Effect of H. pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992; 340: 930-2.
5. Wotherspoon AC, Dagirono C, Diss TC, et al. Regression of primary low-grade B-Cell lymphoma of mucosa-associated lymphoid tissue type after eradication of H. pylori. Lancet 1993; 342: 575-7.
6. Schubert ML. Neuronal and paracrine regulation of gastrin secretion. Gastrin. (Edit) Walsh JH, Raven Press Ltd, New York, 1993; 129-137.
7. Sernka T, Jacobson E. Gastrointestinal physiology the esentials. Gastrin. Second Edition, Williams & Wilkins, Baltimore London, 1983; 48-98.
8. Verndell IM, Harris A, Tapia FJ, et al. Intracellular Topography of immunoreactive gastrin demonstrated using electron immunocytochemistry. Experentia 1983; 39: 713-7.
9. Goodwn CS. Duodenal Ulcer, Campylobacter pylori and the "Leaking-Roof" Concept. Lancet 1988; 2: 1467.
10. Levi S, Beardshall K, Haddad G, et al. Campylobacter pylori and duodenal ulcers: The Gastrin Link. Lancet 1989; 1: 1167-8.
11. Allen JM, Bishop AE, Daly MJ, et al. Effect of inhibition of acid secretion on the regulatory peptides in the rat stomach. Gastroenterology 1986; 90: 900-70.
12. Eissele R, Roakoph B, Koop H, et al. Proliferation of endocrine cells in the rat stomach caused by drug-Induced achlorhydria. Gastroenterology 1991; 101: 70-6.
13. Pawlikovski M, Kabownik M, Lewimski A, et al. Effect of omeprazole on the number of immunoreactive gastrin and somatostatin cells in the rat gastric mucosa. Histol Histopath 1992; 7: 153-6.
14. Olbe L, Hamlet A, Dalenback J, Fandriks L. A Mechanism by which Helicobacter pylori infection of the antrum contributes to the development of duodenal ulcer. Gastroenterology 1996; 10: 1386-94.
15. Mc Cool KEL, El Omar E. Helicobacter pylori and disturbance of gastric function associated with duodenal ulcer disease and castric cancer. Scand J Gastroentorol 1996; 215: 32-7.
16. Tytgat GNJ, Noach LA, Rauws EAJ. Helicobacter Pylori Infection and Duedonal Ulcer Disease Gastroentrol Clin North Am 1993; 22: 127-39.
17. Bobrrzynski A. Hormonal, secretory and morphological alterations in gastric mucosa in the course of Helicobacter pylori eradication in patients with duedonal ulcer and nonulcer dyspepsia. J Physiol Pharmacol 1997; 48: 1-56.
18. Gisbert JP, Boixeda D, Vila T. Basal and stimulated gastrin levels and gastric acid output five months after therapy for Helicobacter pylori eradication in duadenal ulcer patients. J Clin Gastroenterol 1996; 22: 90-5.
19. Park SM, Yoo BC, Lee HR, Yoon JH. Antral Helicobacter pylori infection, Hypergastrinemia and peptic ulcers: effect of eradicating the organism korean J Inter Med 1993; 8: 19-24.
20. Lind Cedervberg C, Forssell H, Olausson M, Olbe L. Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment. Scand J Gastroenterol 1998; 23: 1259-1266.
21. Mattsson H, Sundler F, Carlson K, Hakanson R. Somatostatin cells during long term hypergastrinemia. Gastroenterology 1991; 100: 665.
22. Sundler F, Anderson K, Mattsson H. Year produces reciplocal effects on antral gastrin and somatostatin cells and no effects on endocrine cells in the colon. Digestion 1995; 56: 194-8.
23. Zavros Y, Paterson A, Lambert J, Shulkes A. Expression of progastrin-derived peptides and somatostatin in fundus and antrum of nonulcer dyspepsia subjects with and without Helicobacter pylori infection. Dig Dis Sci 2000; 45: 2058-64.
24. Eissele R, Brunner G, Simon B, et al. Treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasio. Gastroenterology 1997; 122: 770-7.